Publier

$SOL is under pressure, but there’s no need to panic. Goldman Sachs reducing SOL/XRP ETF exposure looks more like tactical risk management than a rejection of Solana’s fundamentals. SOL remains below $100, with the 30D MA near $97.5 as key support. ETF inflows remain strong, while Alpenglow’s October timeline is intact. I’d wait for the FOMC before acting; a recovery above $100 could open $105, then $110.#FOMCRateCallThisWeek #AnthropicIPOOnNasdaq